National Sickle Cell Awareness Month: Guideline-concordant preventive care often lacking

September is National Sickle Cell Awareness Month.
The congressional designation is intended to focus attention on the need for improved treatments and additional research for the condition, which affects an estimated 100,000 people in the United States.
In conjunction with this observation, Healio provides the following updates in sickle cell disease research and treatment.
1. Researchers at Boston Medical Center identified a new small molecule — SR-18292 — that could benefit people with sickle cell disease who do not respond to hydroxyurea. Read more.
2. Hydroxyurea did not affect

September is National Sickle Cell Awareness Month.
The congressional designation is intended to focus attention on the need for improved treatments and additional research for the condition, which affects an estimated 100,000 people in the United States.
In conjunction with this observation, Healio provides the following updates in sickle cell disease research and treatment.
1. Researchers at Boston Medical Center identified a new small molecule — SR-18292 — that could benefit people with sickle cell disease who do not respond to hydroxyurea. Read more.
2. Hydroxyurea did not affect